GlassScriptPhysician profile
Samaris Corona
NPI 1619401296
$2,017.26
in general payments reported to CMS, 2019-2025
18 companies · $678 in 2025
The $678 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $261 · 2023: $571 · 2024: $384 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Education: $197 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.04 |
| Education | $197.34 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $532.04 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $300.43 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $262.46 | 2022-2025 | |
| Abbvie INC. | $155.45 | 2022-2023 | Liletta |
| Hologic Sales and Service, LLC | $144.66 | 2023-2025 | Aptima |
| Merck Sharp & Dohme LLC | $123.21 | 2022-2024 | Gardasil 9, Gardasil |
| Sumitomo Pharma America, INC. | $104.53 | 2023-2025 | Myfembree |
| Organon LLC | $90.43 | 2023-2025 | Nexplanon, Nuvaring |
| Coopersurgical, INC. | $67.32 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $47.68 | 2021-2022 | |
| Evofem Biosciences, INC. | $36.95 | 2021 | |
| Pfizer INC. | $33.45 | 2021-2022 | |
| Baxter Healthcare | $32.62 | 2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $31.53 | 2025 | |
| Biogen, INC. | $22.98 | 2025 | Zurzuvae |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.35 | 2024 | |
| Agile Therapeutics, INC. | $12.17 | 2022 | |
| Intuitive Surgical, INC. | $6.00 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samaris Corona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.